(IN BRIEF) Novartis, through its wholly owned subsidiary Torino Merger Sub Inc., has launched a tender offer to acquire all outstanding shares of Tourmaline Bio, Inc. at USD 48 per share in cash. The offer commenced September 29, 2025, and … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Switzerland
Tagged acquisition, biopharma acquisition, Computershare Trust Company, Hart-Scott-Rodino Act, Innisfree M&A, M&A, Merger Agreement, Novartis, Novartis Commences Tender Offer to Acquire Tourmaline Bio for USD 48 Per Share, Novartis Moves Forward with Acquisition of Tourmaline Bio Through Tender Offer, Novartis Pursues Strategic Acquisition of Tourmaline Bio with USD 48 Per Share Tender, Schedule 14D-9, Schedule TO, SEC filing, shareholder offer, tender offer, Torino Merger Sub, Tourmaline Bio, USD 48 per share
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?